Evidence map›Paper›PMID 33643836›Full record

ArticleJournal of oral and maxillofacial surgery, medicine, and pathology2021

Virucidal activity of oral care products against SARS-CoV-2

Akihiko Komine, Erika Yamaguchi, Nako Okamoto, Kazushi Yamamoto

Abstract read
In one paragraph

Article in Journal of oral and maxillofacial surgery, medicine, and pathology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Vitamin DFrontiers in oral health · 2026
    Trial
  4. Trial
  5. Trial
  6. Trial
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. International journal of dentistry · 2023
    Article
  17. Journal of oral microbiology · 2023
    Article
  18. Article
  19. Article
  20. Virucidal activity and mechanism of action of cetylpyridinium chloride against SARS-CoV-2.Journal of oral and maxillofacial surgery, medicine, and pathology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Akihiko KomineR&D, Sunstar Inc., 1-35-10, Kawanishi-cho, Takatsuki, Osaka, 569-1133, Japan.
Erika YamaguchiR&D, Sunstar Inc., 1-35-10, Kawanishi-cho, Takatsuki, Osaka, 569-1133, Japan.
Nako OkamotoR&D, Sunstar Inc., 1-35-10, Kawanishi-cho, Takatsuki, Osaka, 569-1133, Japan.
Kazushi YamamotoR&D, Sunstar Inc., 1-35-10, Kawanishi-cho, Takatsuki, Osaka, 569-1133, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveCoronavirus disease 2019 (COVID-19) caused by infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide. Since reducing the amount of virus in saliva is considered to prevent broader infection, the Center for Disease Control (CDC) and American Dental Hygienists' Association (ADHA) have recommended use of CPC- or CHX-containing oral care products before the dental procedure. However, there is no certified evidence. So, we examined inactivation of SARS-CoV-2 by oral care products in several countries

methods0.05 % Cetylpyridinium chloride (CPC) mouthwash, 0.05 % CPC toothpaste and 0.30 % CPC spray in Japan; 0.06 % chlorhexidine gluconate (CHX) + 0.05 % CPC mouthwash and 0.12 % CHX + 0.05 % CPC mouthwash in Europe; 0.075 % CPC mouthwash, 0.12 % CHX mouthwash, and 0.20 % delmopinol hydrochloride mouthwash in the USA; and 0.04 % CPC mouthwash in China were assessed for their virucidal activity with ASTM E1052.

resultsThe virus was inactivated

conclusionsThese results suggest that these oral care products in each country may reduce the viral load in the mouth.

Indexed as

CHX (chlorhexidine gluconate)CPC (cetylpyridinium chloride)Delmopinol hydrochlorideSARS-CoV-2Virucidal activity

Identifiers

PMID33643836
PMCPMC7898974

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.